Because discrepant findings related to C3 and FH resulted from preferential analysis of early (mild cognitive impairment, MCI) or late (dementia) AD stages, we hypothesized that C3 and FH levels were altered (in keeping with complement activation) during the transition from MCI to dementia in AD. The gene discussed is C3; the disease is dementia.